Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Conclusion Understanding changes in clinical characteristics and treatment patterns over time among new users of SGLT2i or GLP-1 RA in the US as described in this observational study is important to inform and contextualize future studies assessing cardiorenal outcomes for these and additional treatments, including finerenone, for individuals with CKD and type 2 diabetes
Maintenance strategies become important for sustained benefits
play a neuroprotective role (56)
Journal of Food Protection , 61 (8), 953959
US$ 26.25
US$ 22.80
/assets/images/provider/photos/2805921.jpeg)
US$ 29.22
US$ 29.49
